Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of Medical Virology|February 25, 2009
Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patientsJong Won Choi, Sang Hoon Ahn, Jun Yong Park, et al.Journal of Viral Hepatitis|November 2, 2022
Baseline and on-treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antiviralsSoo Young Hwang, Sung Hwan Yoo, Hye Young Chang, et al.Journal of Medical Virology|September 11, 2003
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapyKyun-Hwan Kim, Kwang-Hee Lee, Hye-Young Chang, et al.Yonsei Medical Journal|October 18, 2018
Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in KoreaJae Cheol Kwon, Hye Young Chang, Oh Young Kwon, et al.Intervirology|April 28, 2012
Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patientHyun Woong Lee, Hyung Joon Kim, Sun Pyo Hong, et al.Journal of Gastroenterology and Hepatology|April 16, 2008
Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot studyHyun Woong Lee, Joung Il Lee, Soon Ho Um, et al.Plos One|July 23, 2013
Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infectionSeung Up Kim, Ki Jun Song, Hye Young Chang, et al.Journal of Hepatology|January 25, 2005
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearanceSang Hoon Ahn, Young Nyun Park, Jun Yong Park, et al.Antiviral Therapy|May 28, 2005
Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridizationHyon-Suk Kim, Kwang-Hyub Han, Sang Hoon Ahn, et al.Journal of Medical Virology|April 22, 2009
Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinomaJa Kyung Kim, Hye Young Chang, Jung Min Lee, et al.Pageof 4